Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Early Laser Treatment for Infants' Birthmarks

By HospiMedica staff writers
Posted on 23 Nov 2006
The best time to treat birthmarks may be before children are even aware they have them, a new laser study suggests.

Researchers at the Laser & Skin Surgery Center of New York (NY, USA) reviewed 51 children who had begun treatment for port-wine stains (PWS) before they were six months old, with the youngest starting treatment at two weeks of age. More...
The infants were laid down with their eyes covered and a laser pulse was delivered, with the average full facial treatment taking less than a minute. The children underwent the treatments every four to six weeks, and received an average of about 10 laser sessions in all.

When the researchers compared pre-treatment photos to photos taken after one year of treatment, they found that an average of 88.6% of the birthmark area had been cleared. Birthmark clearance for individual patients ranged from 65% to 99.7%. None of the infants developed scarring or changes in skin color after treatment. While the children did develop some bruising, none required anesthesia. The study was presented at the annual meeting of the American Society for Dermatologic Surgery, held in Palm Desert (CA, USA) in October 2006.

"The child is kind of startled and crying because they don't know what's going on,” said lead author Dr. Anne Chapas, "but once the treatment is over they're back to normal.”

PWS are vascular birthmarks made of enlarged capillaries in the skin that are present at birth. The rate is three out of 1,000 people. They occur most often on the face but can appear anywhere on the body. Early stains are usually flat and pink in appearance. As the child matures, the color may deepen to a dark red or purplish color.






Related Links:
Laser & Skin Surgery Center of New York

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.